Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hi-Tech Q1 net sales surge
The company has earned gross profit of $33.24m, compared to gross profit of $22.54m, for the same period last year. Hi-Tech’s net income for the first quarter ended
The company has earned gross profit of $33.24m, compared to gross profit of $22.54m, for the same period last year. Hi-Tech’s net income for the first quarter ended
Sleep Formula 39 is a non-prescription sleep aid made up with a proprietary combination of sleep ingredients including 5-HTP, melatonin, GABA and L-Tryptophan which facilitates to improve the
Afatinib is an experimental orally-administered irreversible inhibitor of the erbB family of receptor tyrosine kinases, specifically epidermal growth factor receptor (EGFR) and HER2. The trials, 1200.89, ‘Afatinib (BIBW
The company has enrolled around 240 patients in the trial in US and Taiwan sites. The primary endpoint of the trial is the change in glycated hemoglobin A1c
The results from a placebo-controlled, randomised, multicenter Phase 3 study treatment with abiraterone acetate in conjunction with prednisone or prednisolone resulted in a 35.4% reduction in the risk
Tesamorelin is a growth hormone-releasing factor (GRF) analogue that induces growth hormone production and its anabolic properties have led Theratechnologies to pursue its development in muscle wasting in
AT-406 is an orally available small molecule helps in neutralizing major inhibitors of apoptosis and is anticipated to be effective in treating cancers in conjunction with anti-cancer therapies.
Buccolam is indicated for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years of age. Buccal
The trial is aimed to investigate the safety, pharmacokinetics and tolerability of BAL30072 following multiple ascending intravenous infusions in healthy volunteers. BAL30072 demonstrated safety and tolerability profile in
Haloperidol Injection, USP is also indicated for the control of tics and vocal utterances of Tourette’s disorder. Sagent’s haloperidol injection will be offered in 5mg per ml single-dose